Carcinoembryonic antigen (CEA), a highly glycosylated glycoprotein with a molecular weight of 180,000, is one of the most useful human tumor markers. Provided is a monoclonal antibody Fll-35 against carcinoembryonic antigen (CEA), designated F11-35. The antibody is able to discriminate CEA in tumor tissues from the CEA-related normal antigens.
This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:
• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production
See more details about Hi-Affi™ recombinant antibody benefits.
Download resources about recombinant antibody development and antibody engineering to boost your research.
Select a product category from the dropdown menu below to view related products.
CAT | Product Name | Application | Type |
---|---|---|---|
HPAB-0569-CN | Mouse Anti-CEA Recombinant Antibody (HPAB-0569-CN) | ELISA, FC | Mouse IgG |
HPAB-0570-CN | Human Anti-CEA Recombinant Antibody (HPAB-0570-CN) | ELISA, FC | Humanized IgG |
HPAB-0571-CN | Human Anti-CEA Recombinant Antibody (HPAB-0571-CN) | ELISA, FC | Chimeric (mouse/human) IgG1, κ |
FAMAB-0059YC | Mouse Anti-CEA Recombinant Antibody (clone 2-18) | IF, FuncS | Mouse IgG1, κ |
FAMAB-0060YC | Human Anti-CEA Recombinant Antibody (clone ch2-18) | IF, FuncS | Chimeric (mouse/human) IgG |
There are currently no Customer reviews or questions for FAMAB-0061YC. Click the button above to contact us or submit your feedback about this product.
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.